News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
125 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (27086)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2525)
September (2746)
October (3357)
November (3389)
December (2298)
Day
1 (169)
2 (155)
3 (125)
4 (98)
7 (129)
8 (161)
9 (169)
10 (165)
11 (61)
14 (83)
15 (187)
16 (122)
17 (182)
18 (85)
20 (6)
21 (131)
22 (103)
23 (159)
24 (166)
25 (164)
28 (156)
29 (195)
30 (196)
31 (190)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
7
8
9
10
11
14
15
16
17
18
20
21
22
23
24
25
28
29
30
31
Press Releases
CALQUENCE® (acalabrutinib) granted Priority Review in the US for patients with untreated mantle cell lymphoma
October 3, 2024
·
16 min read
Press Releases
BridgeBio to Present Outcomes Data Through 42 Months from the Open-Label Extension of ATTRibute-CM, the Phase 3 Study of Acoramidis for Treatment of ATTR-CM, at 2024 AHA Scientific Sessions
October 3, 2024
·
2 min read
Press Releases
Soligenix Announces Partnership with Sterling Pharma Solutions
October 3, 2024
·
15 min read
News
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at IDWeek 2024
October 3, 2024
·
3 min read
Drug Development
Immutep Completes Patient Enrolment in Randomised Phase II of AIPAC-003 Trial in Metastatic Breast Cancer
October 3, 2024
·
1 min read
Press Releases
BioIVT to Showcase Industry-Leading Cellular Solutions at the 2024 Meeting on the Mesa
October 3, 2024
·
2 min read
Press Releases
Eupraxia Pharmaceuticals Strengthens Senior Management Team
October 3, 2024
·
8 min read
Press Releases
Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
October 3, 2024
·
5 min read
Press Releases
A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore
October 3, 2024
·
4 min read
Press Releases
Oncocyte Signs Leading Transplant Centers in US and Germany
October 3, 2024
·
6 min read
Previous
9 of 13
Next